Medications

FDA chief says long-awaited opioid review still in the works

A long-awaited review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway at the Food and Drug Administration, the agency's commissioner said Tuesday.

Addiction

Understanding supervised safe injection sites

This week, California Governor Gavin Newsom vetoed a bill that would have allowed supervised injection sites in the state. The legislation would have allowed supervised injection sites to operate in Los Angeles, San Francisco ...

Addiction

Oklahoma reaches opioid settlement with 3 drug companies

Oklahoma officials have reached an opioid settlement with three drug companies that would bring more than $250 million to finance efforts to battle opioid addiction, state Attorney General John O'Connor has announced.

Medications

Medication that lowers risk of overdose underused

Less than half of Americans who received treatment for opioid use disorder over a five-year period were offered a potentially lifesaving medication, researchers at Washington University School of Medicine in St. Louis and ...

page 7 from 40